↓ Skip to main content
What is this page? Embed badge

Lung Cancer and Personalized Medicine

Overview of attention for book
Cover of 'Lung Cancer and Personalized Medicine'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Lung Cancer Statistics.
  3. Altmetric Badge
    Chapter 2 Epidemiology of Lung Cancer.
  4. Altmetric Badge
    Chapter 3 Lung Cancer in Never Smokers.
  5. Altmetric Badge
    Chapter 4 Immune Therapy.
  6. Altmetric Badge
    Chapter 5 Anti-angiogenesis in Personalized Therapy of Lung Cancer.
  7. Altmetric Badge
    Chapter 6 Target Therapy in Lung Cancer.
  8. Altmetric Badge
    Chapter 7 Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: An Update.
  9. Altmetric Badge
    Chapter 8 KRAS-Mutant Lung Cancers in the Era of Targeted Therapy.
  10. Altmetric Badge
    Chapter 9 Anaplastic Lymphoma Kinase (ALK) Signaling in Lung Cancer.
  11. Altmetric Badge
    Chapter 10 Chemotherapy Resistance in Lung Cancer.
  12. Altmetric Badge
    Chapter 11 Current State of Metal-Based Drugs for the Efficient Therapy of Lung Cancers and Lung Metastases.
Attention for Chapter 11: Current State of Metal-Based Drugs for the Efficient Therapy of Lung Cancers and Lung Metastases.
Altmetric Badge

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
14 Mendeley
Summary Dimensions citations
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Current State of Metal-Based Drugs for the Efficient Therapy of Lung Cancers and Lung Metastases.
Chapter number 11
Book title
Lung Cancer and Personalized Medicine
Published in
Advances in experimental medicine and biology, December 2015
DOI 10.1007/978-3-319-24223-1_11
Pubmed ID
26667346
Book ISBNs
978-3-31-924221-7, 978-3-31-924223-1
Authors

Bernhard Biersack, Rainer Schobert

Editors

Aamir Ahmad, Shirish Gadgeel

Abstract

Lung cancer is the second most common cancer in both men and women and thus a leading cause of cancer-related deaths worldwide. New efficient treatments especially for its advanced stages and metastases are desperately needed, particularly with regard to overcoming the resistance which thwarts the efficacy of most clinically established drugs such as the platinum complexes. Glimpses of hope are new metal-based drugs that have emerged over the past decade which displayed efficacy in patients with platinum-resistant tumors and metastases. This chapter provides an overview of the latest developments of such metal-based drugs against lung cancer.

View on publisher site
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 21%
Student > Ph. D. Student 2 14%
Student > Doctoral Student 1 7%
Professor 1 7%
Researcher 1 7%
Other 2 14%
Unknown 4 29%
Readers by discipline Count As %
Chemistry 4 29%
Medicine and Dentistry 3 21%
Biochemistry, Genetics and Molecular Biology 2 14%
Agricultural and Biological Sciences 1 7%
Unknown 4 29%

This page is provided by Altmetric.